---
figid: PMC9009033__10020_2022_469_Fig3_HTML
figtitle: 'ARID1A variations in colorectal cancer: a collaborative review'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9009033
filename: 10020_2022_469_Fig3_HTML.jpg
figlink: /pmc/articles/PMC9009033/figure/Fig3/
number: F3
caption: The mechanism by which the ARID1A variation contributes to the pathogenesis
  of CRCs. ARID1A, a subunit of the chromatin remodeling protein SWI/SNF, is considered
  to be associated with the tumorigenesis and the progression of CRCs. The process
  is initiated by the mutation of multiple genes (i.e., TP53, ARID domain-containing
  gene family, APC, FBXW7, PIK3CA, PD-L1, and KRAS), the dysregulation of several
  signaling pathways (i.e., PI3K/Akt signaling, MEK/ERK pathway, WNT pathway, AURKA-mediated
  signaling, and DNA repair pathways), chromatin remodeling, mismatch repair deficiency,
  and DNA hypermethylation, leading to the cell cycle arrest, proliferation, and survival
  of the CRC cells. ARID1A AT-rich interaction domain 1A, APC adenomatous polyposis
  coli, FBXW7 F-Box and WD repeat domain containing 7, PIK3CA phosphatidylinositol-4,5-bisphosphate
  3-kinase catalytic subunit α, SWI/SNF SWItch/Sucrose non-fermenting, PD-L1 programmed
  death ligand 1, KRAS Kirsten rat sarcoma viral oncogene homolog, AURKA aurora kinase
  A
papertitle: 'Roles of ARID1A variations in colorectal cancer: a collaborative review.'
reftext: Shankun Zhao, et al. Mol Med. 2022;28:42.
year: '2022'
doi: 10.1186/s10020-022-00469-6
journal_title: Molecular Medicine
journal_nlm_ta: Mol Med
publisher_name: BioMed Central
keywords: ARID1A variations | Colorectal cancer (CRC) | Biomarker | Prognosis | Pathogenesis
automl_pathway: 0.9438119
figid_alias: PMC9009033__F3
figtype: Figure
redirect_from: /figures/PMC9009033__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9009033__10020_2022_469_Fig3_HTML.html
  '@type': Dataset
  description: The mechanism by which the ARID1A variation contributes to the pathogenesis
    of CRCs. ARID1A, a subunit of the chromatin remodeling protein SWI/SNF, is considered
    to be associated with the tumorigenesis and the progression of CRCs. The process
    is initiated by the mutation of multiple genes (i.e., TP53, ARID domain-containing
    gene family, APC, FBXW7, PIK3CA, PD-L1, and KRAS), the dysregulation of several
    signaling pathways (i.e., PI3K/Akt signaling, MEK/ERK pathway, WNT pathway, AURKA-mediated
    signaling, and DNA repair pathways), chromatin remodeling, mismatch repair deficiency,
    and DNA hypermethylation, leading to the cell cycle arrest, proliferation, and
    survival of the CRC cells. ARID1A AT-rich interaction domain 1A, APC adenomatous
    polyposis coli, FBXW7 F-Box and WD repeat domain containing 7, PIK3CA phosphatidylinositol-4,5-bisphosphate
    3-kinase catalytic subunit α, SWI/SNF SWItch/Sucrose non-fermenting, PD-L1 programmed
    death ligand 1, KRAS Kirsten rat sarcoma viral oncogene homolog, AURKA aurora
    kinase A
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - NRAS
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - ARID2
  - ELK1
  - KCNH4
  - KCNH8
  - FBXW7
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - SMARCA1
  - ARID4A
  - ARID1A
  - ARID1B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - PIK3CA
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - AURKA
  - PLK1
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - APC
  - PROC
  - BTG3
---
